Europe Castrate-Resistant Prostate Cancer Market

Europe Castrate-Resistant Prostate Cancer Market By Therapy (Hormonal Therapy, Immunotherapy, Chemotherapy and Radiotherapy), By Country, Industry Analysis and Forecast, 2020 - 2026

Report Id: KBV-5242 Publication Date: February-2021 Number of Pages: 64
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
TABLE 1 Europe Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 2 Europe Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 3 Europe Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 4 Europe Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 5 Europe Hormonal Therapy Market by Country, 2016 - 2019, USD Million
TABLE 6 Europe Hormonal Therapy Market by Country, 2020 - 2026, USD Million
TABLE 7 Europe Immunotherapy Market by Country, 2016 - 2019, USD Million
TABLE 8 Europe Immunotherapy Market by Country, 2020 - 2026, USD Million
TABLE 9 Europe Chemotherapy Market by Country, 2016 - 2019, USD Million
TABLE 10 Europe Chemotherapy Market by Country, 2020 - 2026, USD Million
TABLE 11 Europe Radiotherapy Market by Country, 2016 - 2019, USD Million
TABLE 12 Europe Radiotherapy Market by Country, 2020 - 2026, USD Million
TABLE 13 Europe Castrate-resistant Prostate Cancer Market by Country, 2016 - 2019, USD Million
TABLE 14 Europe Castrate-resistant Prostate Cancer Market by Country, 2020 - 2026, USD Million
TABLE 15 Germany Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 16 Germany Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 17 Germany Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 18 Germany Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 19 UK Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 20 UK Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 21 UK Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 22 UK Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 23 France Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 24 France Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 25 France Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 26 France Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 27 Russia Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 28 Russia Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 29 Russia Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 30 Russia Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 31 Spain Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 32 Spain Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 33 Spain Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 34 Spain Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 35 Italy Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 36 Italy Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 37 Italy Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 38 Italy Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 39 Rest of Europe Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 40 Rest of Europe Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 41 Rest of Europe Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 42 Rest of Europe Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 43 Key Information – Sanofi S.A.
TABLE 44 Key information –Johnson and Johnson
TABLE 45 Key Information – Pfizer, Inc.
TABLE 46 Key Information – Bayer AG
TABLE 47 Key Information – Abbott Laboratories
TABLE 48 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 49 Key Information – Northwest Biotherapeutics, Inc.
TABLE 50 Key Information – Active Biotech AB
TABLE 51 key information – Astellas Pharma, Inc.
TABLE 52 Key Information – Dendreon Pharmaceuticals LLC

List of Figures
FIG 1 Methodology for the research
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo